Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Carolina Schinke

Concepts (322)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
80
2025
3050
9.260
Why?
Antibodies, Bispecific
10
2025
94
3.780
Why?
B-Cell Maturation Antigen
9
2025
98
2.480
Why?
Hematopoietic Stem Cell Transplantation
8
2024
606
1.900
Why?
Bone Marrow
11
2024
363
1.320
Why?
Neoplasm, Residual
7
2025
173
1.320
Why?
Monoclonal Gammopathy of Undetermined Significance
5
2025
125
1.310
Why?
Leukemia, Plasma Cell
2
2020
33
1.290
Why?
Humans
95
2025
52593
1.270
Why?
Neoplasms, Plasma Cell
3
2024
37
1.250
Why?
Paraproteinemias
2
2022
74
1.240
Why?
Positron-Emission Tomography
5
2025
303
1.180
Why?
Immunotherapy, Adoptive
6
2024
167
1.130
Why?
Diffusion Magnetic Resonance Imaging
3
2025
133
1.070
Why?
Neoplasm Recurrence, Local
8
2025
643
1.060
Why?
Aged
29
2025
10191
1.000
Why?
Immunoglobulin Light Chains
2
2017
90
0.980
Why?
Prognosis
18
2025
2118
0.930
Why?
Transplantation, Autologous
9
2024
488
0.920
Why?
Immunoglobulins, Intravenous
1
2025
63
0.900
Why?
Gene Expression Regulation, Neoplastic
10
2024
857
0.890
Why?
Myelodysplastic Syndromes
5
2016
86
0.860
Why?
Immunoconjugates
2
2022
37
0.850
Why?
Mutation
8
2022
1344
0.840
Why?
Middle Aged
28
2025
13096
0.840
Why?
Antibodies, Monoclonal
6
2023
478
0.780
Why?
Male
36
2025
26863
0.760
Why?
Leukemia, Myeloid, Acute
4
2019
203
0.750
Why?
Gene Expression Profiling
11
2025
1110
0.740
Why?
Health Personnel
1
2024
252
0.730
Why?
Adult
24
2025
14170
0.730
Why?
Testis
1
2021
72
0.680
Why?
Signal Transduction
6
2024
1714
0.670
Why?
Aged, 80 and over
12
2025
3420
0.660
Why?
Tumor Microenvironment
5
2024
255
0.650
Why?
Hematopoietic Stem Cells
3
2019
188
0.640
Why?
Plasma Cells
6
2025
239
0.630
Why?
Quality of Life
1
2025
882
0.620
Why?
Cell Proliferation
8
2023
1029
0.620
Why?
Female
32
2025
28262
0.610
Why?
Clonal Evolution
4
2024
59
0.610
Why?
Gene Expression
3
2018
623
0.600
Why?
Clinical Trials as Topic
6
2023
472
0.550
Why?
Antineoplastic Combined Chemotherapy Protocols
5
2024
1031
0.540
Why?
Translocation, Genetic
5
2021
265
0.530
Why?
Thoracic Neoplasms
1
2016
13
0.500
Why?
Plasmacytoma
1
2016
43
0.480
Why?
Receptors, Interleukin-8B
1
2015
5
0.470
Why?
Survival Analysis
8
2024
673
0.460
Why?
Interleukin-8
1
2015
86
0.460
Why?
Receptors, G-Protein-Coupled
2
2024
57
0.420
Why?
Antineoplastic Agents
7
2024
1221
0.410
Why?
Combined Modality Therapy
4
2024
639
0.400
Why?
Fluorodeoxyglucose F18
5
2021
188
0.390
Why?
Neutropenia
2
2023
115
0.380
Why?
DNA Methylation
4
2020
592
0.370
Why?
Oncogene Proteins, Fusion
2
2018
60
0.360
Why?
Neoplasms, Second Primary
2
2024
77
0.360
Why?
Chromosomes, Human, Pair 1
3
2023
96
0.360
Why?
Polycomb Repressive Complex 2
2
2021
48
0.350
Why?
Stem Cell Transplantation
3
2022
187
0.340
Why?
Evolution, Molecular
2
2021
95
0.340
Why?
Epigenesis, Genetic
4
2020
407
0.340
Why?
Tretinoin
1
2010
53
0.330
Why?
Treatment Outcome
10
2025
5486
0.320
Why?
Cell Line, Tumor
7
2024
1436
0.320
Why?
Risk Assessment
4
2024
1350
0.310
Why?
Transcription Factors
3
2023
566
0.310
Why?
Transcriptome
3
2025
368
0.300
Why?
Immunoglobulin kappa-Chains
2
2021
22
0.300
Why?
Disease Progression
8
2025
873
0.300
Why?
DNA-Binding Proteins
2
2021
426
0.280
Why?
Neoplasm Proteins
3
2020
328
0.280
Why?
Melanoma
1
2010
279
0.270
Why?
RANK Ligand
2
2024
187
0.250
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
2024
92
0.240
Why?
Biopsy
2
2018
607
0.240
Why?
Radiopharmaceuticals
3
2021
205
0.230
Why?
Skin Neoplasms
1
2010
500
0.230
Why?
Chemokine CCL3
1
2024
13
0.230
Why?
HMGB1 Protein
1
2024
21
0.230
Why?
Retrospective Studies
7
2025
6671
0.230
Why?
Dexamethasone
3
2024
440
0.230
Why?
T-Lymphocytes
5
2024
329
0.220
Why?
Kaplan-Meier Estimate
3
2021
485
0.220
Why?
Sialic Acid Binding Ig-like Lectin 2
1
2024
2
0.220
Why?
Chemokine CXCL12
1
2024
34
0.220
Why?
Antigens, CD19
1
2024
28
0.220
Why?
Mutation Rate
2
2021
36
0.210
Why?
Bone Resorption
2
2024
302
0.210
Why?
Recurrence
6
2025
683
0.210
Why?
Genome-Wide Association Study
1
2024
187
0.210
Why?
Myeloproliferative Disorders
1
2023
31
0.210
Why?
Cell Cycle
2
2021
240
0.200
Why?
Neoplasm Staging
2
2024
768
0.200
Why?
Genomics
2
2023
270
0.190
Why?
Proto-Oncogene Proteins B-raf
2
2020
80
0.190
Why?
Drug Resistance, Neoplasm
1
2024
327
0.190
Why?
Qualitative Research
1
2024
362
0.190
Why?
Osteolysis
1
2022
75
0.190
Why?
Drug Approval
1
2022
43
0.190
Why?
Waldenstrom Macroglobulinemia
1
2022
40
0.190
Why?
Osteocytes
1
2024
226
0.180
Why?
Lymphoma, B-Cell
1
2022
62
0.180
Why?
Bone Marrow Transplantation
1
2022
113
0.180
Why?
Polymorphism, Single Nucleotide
1
2024
506
0.180
Why?
Hematologic Diseases
1
2021
21
0.180
Why?
Epigenomics
1
2021
75
0.180
Why?
Patient Participation
1
2022
69
0.180
Why?
Genetic Predisposition to Disease
1
2024
528
0.180
Why?
Chromosome Deletion
2
2023
141
0.180
Why?
Abnormal Karyotype
1
2021
6
0.180
Why?
Mice
6
2024
5958
0.180
Why?
Drug Design
2
2013
121
0.180
Why?
Myeloma Proteins
1
2021
26
0.180
Why?
Immunoglobulin A
1
2021
46
0.170
Why?
Risk Factors
8
2024
3952
0.170
Why?
Communicable Diseases
1
2021
55
0.170
Why?
Antibodies, Monoclonal, Humanized
1
2022
237
0.170
Why?
Genes, Tumor Suppressor
2
2021
73
0.170
Why?
Hematologic Neoplasms
1
2022
106
0.170
Why?
Gene Expression Regulation, Leukemic
1
2020
32
0.170
Why?
Salvage Therapy
1
2021
136
0.170
Why?
Immunoglobulin G
1
2021
195
0.170
Why?
Practice Guidelines as Topic
1
2023
496
0.170
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.160
Why?
Neoplasm Invasiveness
1
2021
278
0.160
Why?
Bone Diseases
1
2021
95
0.160
Why?
Gene Amplification
1
2019
58
0.160
Why?
Chromosomal Instability
1
2019
16
0.160
Why?
Gene Regulatory Networks
1
2020
111
0.160
Why?
Hematopoiesis, Extramedullary
1
2019
9
0.160
Why?
Atrial Fibrillation
1
2022
201
0.160
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
10
0.150
Why?
United States
3
2024
5227
0.150
Why?
Comorbidity
1
2021
631
0.150
Why?
Models, Statistical
1
2020
231
0.150
Why?
Healthcare Disparities
1
2022
300
0.150
Why?
Sulfonamides
1
2019
134
0.150
Why?
Spleen
1
2019
171
0.150
Why?
Animals
8
2024
13507
0.150
Why?
Spinal Fractures
1
2018
38
0.150
Why?
Phosphotransferases
1
2018
17
0.140
Why?
Bacteremia
1
2019
90
0.140
Why?
Adipocytes
1
2018
130
0.140
Why?
Cell Differentiation
3
2022
673
0.140
Why?
Gene Rearrangement
1
2018
76
0.140
Why?
Disease-Free Survival
4
2019
464
0.140
Why?
Kidney Function Tests
1
2017
55
0.140
Why?
Hexokinase
1
2017
16
0.140
Why?
Chromosomes, Human, Pair 17
1
2017
35
0.130
Why?
Calcification, Physiologic
1
2017
42
0.130
Why?
Glomerular Filtration Rate
1
2017
130
0.130
Why?
Chromosome Aberrations
2
2023
297
0.130
Why?
Survival Rate
4
2020
952
0.130
Why?
Pelvis
1
2017
67
0.130
Why?
Histoplasma
1
2016
24
0.130
Why?
CA-125 Antigen
1
2016
16
0.130
Why?
HIV Infections
1
2021
388
0.130
Why?
Receptor, TIE-2
1
2016
16
0.130
Why?
Cardiomyopathy, Restrictive
1
2016
5
0.130
Why?
Histoplasmosis
1
2016
47
0.130
Why?
Urea
1
2016
82
0.130
Why?
Indazoles
1
2016
47
0.120
Why?
p38 Mitogen-Activated Protein Kinases
1
2016
95
0.120
Why?
Gene Expression Regulation, Enzymologic
1
2017
181
0.120
Why?
Remission Induction
3
2024
219
0.120
Why?
Gastrointestinal Diseases
1
2016
125
0.120
Why?
Tumor Suppressor Protein p53
1
2017
224
0.120
Why?
Proteasome Inhibitors
1
2016
105
0.120
Why?
Immunologic Factors
1
2016
117
0.120
Why?
Cell Cycle Checkpoints
1
2015
32
0.120
Why?
Time Factors
2
2021
3000
0.110
Why?
Kidney Diseases
1
2017
231
0.110
Why?
Cluster Analysis
1
2015
233
0.110
Why?
Xenograft Model Antitumor Assays
1
2015
222
0.110
Why?
Thrombopoiesis
1
2014
5
0.110
Why?
Hydrazines
1
2014
18
0.110
Why?
Neoplastic Stem Cells
1
2015
93
0.110
Why?
Myocardium
1
2017
479
0.110
Why?
Benzoates
1
2014
21
0.110
Why?
Immunotherapy
1
2016
244
0.110
Why?
Cystatin M
2
2024
19
0.100
Why?
Disease Models, Animal
2
2016
1486
0.100
Why?
Cell Survival
1
2015
602
0.100
Why?
Cross-Sectional Studies
3
2023
1686
0.100
Why?
Pyrazoles
1
2014
114
0.100
Why?
Chromosomes, Human, Pair 7
1
2012
30
0.100
Why?
Clone Cells
2
2023
76
0.100
Why?
Flow Cytometry
2
2012
400
0.100
Why?
STAT3 Transcription Factor
1
2012
87
0.090
Why?
Cardiovascular Diseases
1
2017
495
0.090
Why?
Chromatin
2
2024
141
0.090
Why?
Cell Transformation, Neoplastic
1
2013
184
0.090
Why?
Thalidomide
1
2014
378
0.090
Why?
Follow-Up Studies
3
2024
2291
0.090
Why?
In Situ Hybridization, Fluorescence
2
2023
263
0.090
Why?
Leukemia, Promyelocytic, Acute
1
2010
11
0.080
Why?
Luciferases
1
2010
50
0.080
Why?
Response Elements
1
2010
29
0.080
Why?
Gene Silencing
1
2010
120
0.080
Why?
Alleles
2
2021
278
0.080
Why?
Tumor Burden
2
2020
136
0.080
Why?
Recombinant Fusion Proteins
1
2010
175
0.080
Why?
Transfection
1
2010
369
0.080
Why?
Molecular Structure
1
2010
315
0.080
Why?
Histones
2
2021
316
0.080
Why?
Apoptosis
2
2014
1121
0.080
Why?
DNA Copy Number Variations
2
2021
117
0.070
Why?
Syndecan-1
2
2021
73
0.070
Why?
Case-Control Studies
2
2024
1202
0.060
Why?
Tumor Cells, Cultured
2
2020
448
0.060
Why?
Imaging, Three-Dimensional
2
2017
151
0.060
Why?
Gene Expression Regulation
1
2010
1006
0.060
Why?
Transmembrane Activator and CAML Interactor Protein
1
2024
6
0.060
Why?
Mendelian Randomization Analysis
1
2024
7
0.060
Why?
ROC Curve
1
2025
254
0.060
Why?
Telomere
1
2024
38
0.060
Why?
Arkansas
2
2021
2029
0.060
Why?
Mitogen-Activated Protein Kinase Kinases
1
2024
34
0.050
Why?
Ferritins
1
2024
36
0.050
Why?
Killer Cells, Natural
1
2024
115
0.050
Why?
Myeloid Progenitor Cells
1
2023
17
0.050
Why?
X-Ray Microtomography
1
2024
79
0.050
Why?
CD8-Positive T-Lymphocytes
1
2024
132
0.050
Why?
Antibodies
1
2024
150
0.050
Why?
Receptors, Antigen, T-Cell
1
2023
51
0.050
Why?
B-Lymphocytes
1
2024
180
0.050
Why?
Demography
1
2023
92
0.050
Why?
Cell Communication
1
2023
72
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Neoplasms
1
2013
1308
0.050
Why?
Patients
1
2022
51
0.050
Why?
Geography
1
2022
66
0.050
Why?
Myeloid Differentiation Factor 88
1
2022
34
0.050
Why?
Patient Selection
1
2023
266
0.050
Why?
United States Food and Drug Administration
1
2022
96
0.050
Why?
Oncogenes
1
2021
60
0.050
Why?
Infant
1
2010
3720
0.050
Why?
Phylogeny
1
2022
234
0.050
Why?
Tomography, X-Ray Computed
2
2017
1162
0.040
Why?
SOXC Transcription Factors
1
2021
13
0.040
Why?
Transcriptional Activation
1
2021
128
0.040
Why?
Lymphoma, Large B-Cell, Diffuse
1
2022
106
0.040
Why?
Pyrimidines
1
2022
200
0.040
Why?
Proto-Oncogene Proteins p21(ras)
1
2021
69
0.040
Why?
Cyclin D2
1
2020
21
0.040
Why?
Aneuploidy
1
2020
18
0.040
Why?
Proto-Oncogene Proteins c-maf
1
2020
19
0.040
Why?
Chromosomes, Human, Pair 4
1
2020
30
0.040
Why?
ras Proteins
1
2020
64
0.040
Why?
Histone Code
1
2020
32
0.040
Why?
Cyclin D1
1
2020
57
0.040
Why?
Chromosomes, Human, Pair 11
1
2020
55
0.040
Why?
Genome, Human
1
2021
121
0.040
Why?
Chromosomes, Human, Pair 14
1
2020
75
0.040
Why?
DNA, Neoplasm
1
2020
146
0.040
Why?
Protein Kinase Inhibitors
1
2022
228
0.040
Why?
DNA Mutational Analysis
1
2020
180
0.040
Why?
Osteoclasts
1
2022
428
0.040
Why?
Genetic Variation
1
2020
230
0.040
Why?
Health Status Disparities
1
2022
216
0.040
Why?
High-Throughput Nucleotide Sequencing
1
2020
179
0.040
Why?
Multivariate Analysis
1
2021
602
0.040
Why?
Computational Biology
1
2020
211
0.040
Why?
Gram-Positive Bacterial Infections
1
2019
30
0.040
Why?
Pseudomonas Infections
1
2019
54
0.040
Why?
Syndrome
1
2019
253
0.040
Why?
Fractures, Compression
1
2018
17
0.040
Why?
Randomized Controlled Trials as Topic
1
2021
600
0.040
Why?
Promoter Regions, Genetic
1
2020
474
0.040
Why?
Receptor Protein-Tyrosine Kinases
1
2018
52
0.040
Why?
Protein-Tyrosine Kinases
1
2018
89
0.030
Why?
False Positive Reactions
1
2017
63
0.030
Why?
Bone and Bones
1
2021
494
0.030
Why?
Amino Acid Sequence
1
2018
574
0.030
Why?
Itraconazole
1
2016
38
0.030
Why?
beta-Glucans
1
2016
23
0.030
Why?
Alkaline Phosphatase
1
2017
93
0.030
Why?
Databases, Factual
1
2020
715
0.030
Why?
Genes, ras
1
2016
43
0.030
Why?
Angiopoietin-1
1
2016
16
0.030
Why?
Amphotericin B
1
2016
104
0.030
Why?
Genes, p53
1
2016
52
0.030
Why?
Ileum
1
2016
89
0.030
Why?
Intestinal Obstruction
1
2016
38
0.030
Why?
NF-kappa B
1
2018
329
0.030
Why?
Glycolysis
1
2016
73
0.030
Why?
Gene Knockdown Techniques
1
2016
110
0.030
Why?
Colonoscopy
1
2016
108
0.030
Why?
Models, Genetic
1
2016
172
0.030
Why?
Genomic Instability
1
2016
89
0.030
Why?
Fever
1
2016
113
0.030
Why?
Drug Screening Assays, Antitumor
1
2016
136
0.030
Why?
Image Interpretation, Computer-Assisted
1
2016
97
0.030
Why?
Staphylococcal Infections
1
2019
280
0.030
Why?
Logistic Models
1
2018
934
0.030
Why?
Phosphatidylinositol 3-Kinases
1
2016
150
0.030
Why?
Heart
1
2017
361
0.030
Why?
Proportional Hazards Models
1
2016
444
0.030
Why?
Algorithms
1
2018
668
0.030
Why?
Echocardiography
1
2017
416
0.030
Why?
Weight Loss
1
2016
250
0.030
Why?
Megakaryocyte Progenitor Cells
1
2014
1
0.030
Why?
Young Adult
1
2024
4337
0.030
Why?
Antifungal Agents
1
2016
347
0.030
Why?
Longitudinal Studies
1
2016
747
0.030
Why?
Models, Immunological
1
2013
8
0.030
Why?
Chemistry, Pharmaceutical
1
2013
35
0.030
Why?
Early Diagnosis
1
2013
87
0.020
Why?
Karyotyping
1
2012
78
0.020
Why?
Azacitidine
1
2012
39
0.020
Why?
Primary Cell Culture
1
2012
62
0.020
Why?
Cell Lineage
1
2012
88
0.020
Why?
Polymerase Chain Reaction
1
2013
460
0.020
Why?
Child
1
2024
7229
0.020
Why?
Antigens, CD
1
2012
216
0.020
Why?
Enzyme Inhibitors
1
2013
372
0.020
Why?
Magnetic Resonance Imaging
1
2017
1545
0.020
Why?
Cytokines
1
2013
626
0.020
Why?
Reproducibility of Results
1
2013
1217
0.020
Why?
Cohort Studies
1
2013
1553
0.020
Why?
Schinke's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description